FHB
First Hawaiian, Inc.
FHB offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has the edge over FHB overall, supported by stronger fundamentals and stronger modeled upside.
FHB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
FHB's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like FHB.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
FHB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $22.79 | -7.6% |
| Forward | 10x | $24.67 | — |
| Current | 11x | $24.67 | — |
| Fair | 13x | $28.33 | +15% |
| Expensive | 14x | $31.75 | +29% |
Historical ranges are pointers, not guarantees.
FHB has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
FHB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for FHB, but weaker profitability. However, they disagree widely on these estimates.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over FHB on the outlook, with more favorable profitability expectations.
FHB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.42 | +8.7% |
| Q3 2026 | $2.23 | +8.8% |
| Q2 2026 | $2.30 | +19% |
| Q1 2026 | $2.28 | +24% |
| Q4 2025 | $2.20 | +23% |
| Q3 2025 | $2.05 | +17% |
| Q2 2025 | $1.94 | +12% |
| Q1 2025 | $1.84 | +5.7% |
| Q4 2024 | $1.79 | -2.7% |
FHB earned $2.23 per share over the past year, up 8.8% from the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over FHB on earnings, with more consistent year-over-year improvement.
FHB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $230.2M | +1.7% |
| Q2 2026 | $231.3M | +6.3% |
| Q1 2026 | $220.3M | +4.4% |
| Q4 2025 | $225.9M | +20% |
| Q3 2025 | $226.4M | +7.8% |
| Q2 2025 | $217.5M | +6.3% |
| Q1 2025 | $211M | +2.5% |
| Q4 2024 | $188.1M | -10% |
FHB's revenue has grown year over year for seven quarters in a row: $230M last quarter, up 1.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | -21 points |
| Q2 2026 | 41% | +0.7 points |
| Q1 2026 | 40% | +3.2 points |
| Q4 2025 | 41% | +6.8 points |
| Q3 2025 | 42% | +6.1 points |
| Q2 2025 | 41% | +1 points |
| Q1 2025 | 36% | +2.1 points |
| Q4 2024 | 34% | +4.7 points |
FHB's operating margin was 22% last quarter, down 21 points from the same quarter a year ago, near the bottom of its range since 2019.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over FHB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over FHB on profitability, with a higher operating margin.
FHB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $101.8M | +106% |
| Q2 2026 | $7.7M | -94% |
| Q1 2026 | $155.4M | +443% |
| Q4 2025 | $100M | -2.4% |
| Q3 2025 | $49.5M | -5.3% |
| Q2 2025 | $125.2M | +73% |
| Q1 2025 | $28.6M | -54% |
| Q4 2024 | $102.5M | +206% |
FHB has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
FHB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +139K shares |
| 1 year | -2% | -2.5M shares |
| 3 years | -4.3% | -5.5M shares |
| 5 years | -5.2% | -6.7M shares |
| Available history | -8.2% | -10.9M shares |
FHB has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $32M |
| Q4 2025 | $26M |
| Q3 2025 | $24M |
| Q2 2025 | $25M |
| Q1 2025 | $25M |
| Q4 2022 | — |
FHB spent $58M buying back its own shares over the past year.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
FHB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
FHB has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
FHB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.9 | Neutral |
| Stochastic | 20.0 | Neutral |
FHB's weekly RSI is 38 (neutral) and its Stochastic is 20 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
FHB PE vs Financial Services Sector
| Metric | FHB | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 15% below |
| PE % | 23 | 63 | 40 pts below |
FHB has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
FHB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.0 | 1.5% below |
| 20 week MA | $26.5 | 7% below |
| 50 week MA | $26.4 | 6.7% below |
| 100 week MA | $25.6 | 3.7% below |
| 200 week MA | $23.6 | 4.5% above |
FHB has fallen below most of its moving averages, though it's still 4.5% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over FHB on trend strength, trading above more of its moving averages.
FHB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.9 | $23.2 | -20% |
| 2021 | $23.2 | $26.9 | +16% |
| 2022 | $26.9 | $25.5 | -5.1% |
| 2023 | $25.5 | $22.9 | -10% |
| 2024 | $22.9 | $26.0 | +14% |
| 2025 | $26.0 | $26.1 | +0.4% |
| 2026 YTD | $26.1 | $24.7 | -5.3% |
FHB has finished lower in three of the last six years. It's down 5.3% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over FHB on returns for 2026, with the stronger performance.